Cancer Research Annual Meeting 2010  2010 Workshops
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, L. C.
Right arrow Articles by Watson, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, L. C.
Right arrow Articles by Watson, P. H.
[Cancer Research 60, 6266-6271, November 15, 2000]
© 2000 American Association for Cancer Research


Advances in Brief

Altered Expression of Estrogen Receptor Coregulators during Human Breast Tumorigenesis1

Leigh C. Murphy2, Sharon L. R. Simon, Alicia Parkes, Etienne Leygue, Helmut Dotzlaw, Linda Snell, Sandra Troup, Adewale Adeyinka and Peter H. Watson

Departments of Biochemistry and Medical Genetics [L. C. M., S. L. R. S., A. P., E. L., H. D.] and Pathology [L. S., S. T., A. A., P. H. W.], University of Manitoba, Faculty of Medicine, Winnipeg, Manitoba R3E OW3, Canada

The hypothesis that altered expression of specific coactivators/repressors of the estrogen receptor occurs during human breast tumorigenesis in vivo is examined in this study. Using in situ hybridization and reverse transcription-PCR assays, the expression of two coactivators (SRA and AIB1) and one repressor (REA) of the estrogen receptor was compared between matched breast tumors and adjacent normal human breast tissue. The levels of SRA and AIB1 mRNA were increased in tumors compared with normal tissues (n = 19; Wilcoxon matched pairs test; P < 0.01). In contrast, the expression of REA mRNA was not different between tumors and normal tissues (n = 19; Wilcoxon; P = 0.110). The ratios of AIB1:REA and SRA:REA were higher (Wilcoxon; P < 0.05) in tumors compared with normal tissues. Furthermore, SRA:AIB1 was higher (Wilcoxon; P = 0.0058) in tumors compared with normal tissues. Although our study is small, these data are consistent with the above hypothesis and suggest that such alterations may have a role in the altered estrogen action occurring during breast tumorigenesis.




This article has been cited by other articles:


Home page
Ann OncolHome page
S. Alkner, P.-O. Bendahl, D. Grabau, K. Lovgren, O. Stal, L. Ryden, M. Ferno, and on behalf of the South Swedish and South-East Swed
AIB1 is a predictive factor for tamoxifen response in premenopausal women
Ann. Onc., February 1, 2010; 21(2): 238 - 244.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
J. Yang and M. J Young
The mineralocorticoid receptor and its coregulators
J. Mol. Endocrinol., August 1, 2009; 43(2): 53 - 64.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. Cooper, J. Guo, Y. Yan, S. Chooniedass-Kothari, F. Hube, M. K. Hamedani, L. C. Murphy, Y. Myal, and E. Leygue
Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides
Nucleic Acids Res., July 1, 2009; 37(13): 4518 - 4531.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
X. Zhao, J. R. Patton, S. K. Ghosh, N. Fischel-Ghodsian, L. Shen, and R. A. Spanjaard
Pus3p- and Pus1p-Dependent Pseudouridylation of Steroid Receptor RNA Activator Controls a Functional Switch that Regulates Nuclear Receptor Signaling
Mol. Endocrinol., March 1, 2007; 21(3): 686 - 699.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Kirkegaard, L. M. McGlynn, F. M. Campbell, S. Muller, S. M. Tovey, B. Dunne, K. V. Nielsen, T. G. Cooke, and J. M.S. Bartlett
Amplified in Breast Cancer 1 in Human Epidermal Growth Factor Receptor-Positive Tumors of Tamoxifen-Treated Breast Cancer Patients
Clin. Cancer Res., March 1, 2007; 13(5): 1405 - 1411.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Naeem, D. Cheng, Q. Zhao, C. Underhill, M. Tini, M. T. Bedford, and J. Torchia
The Activity and Stability of the Transcriptional Coactivator p/CIP/SRC-3 Are Regulated by CARM1-Dependent Methylation
Mol. Cell. Biol., January 1, 2007; 27(1): 120 - 134.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Mussi, L. Liao, S.-E. Park, P. Ciana, A. Maggi, B. S. Katzenellenbogen, J. Xu, and B. W. O'Malley
Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland
PNAS, November 7, 2006; 103(45): 16716 - 16721.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Glaros, N. Atanaskova, C. Zhao, D. F. Skafar, and K. B. Reddy
Activation Function-1 Domain of Estrogen Receptor Regulates the Agonistic and Antagonistic Actions of Tamoxifen
Mol. Endocrinol., May 1, 2006; 20(5): 996 - 1008.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
J. M. Hall and D. P. McDonnell
Coregulators in Nuclear Estrogen Receptor Action: From Concept to Therapeutic Targeting
Mol. Interv., December 1, 2005; 5(6): 343 - 357.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lanzino, F. De Amicis, M. J. McPhaul, S. Marsico, M. L. Panno, and S. Ando
Endogenous Coactivator ARA70 Interacts with Estrogen Receptor {alpha} (ER{alpha}) and Modulates the Functional ER{alpha}/Androgen Receptor Interplay in MCF-7 Cells
J. Biol. Chem., May 27, 2005; 280(21): 20421 - 20430.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. C. Gutierrez, S. Detre, S. Johnston, S. K. Mohsin, J. Shou, D. C. Allred, R. Schiff, C. K. Osborne, and M. Dowsett
Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase
J. Clin. Oncol., April 10, 2005; 23(11): 2469 - 2476.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S.-E. Park, J. Xu, A. Frolova, L. Liao, B. W. O'Malley, and B. S. Katzenellenbogen
Genetic Deletion of the Repressor of Estrogen Receptor Activity (REA) Enhances the Response to Estrogen in Target Tissues In Vivo
Mol. Cell. Biol., March 1, 2005; 25(5): 1989 - 1999.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. T. Tilli, R. Reiter, A. S. Oh, R. T. Henke, K. McDonnell, G. I. Gallicano, P. A. Furth, and A. T. Riegel
Overexpression of an N-Terminally Truncated Isoform of the Nuclear Receptor Coactivator Amplified in Breast Cancer 1 Leads to Altered Proliferation of Mammary Epithelial Cells in Transgenic Mice
Mol. Endocrinol., March 1, 2005; 19(3): 644 - 656.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Oh, H.-J. List, R. Reiter, A. Mani, Y. Zhang, E. Gehan, A. Wellstein, and A. T. Riegel
The Nuclear Receptor Coactivator AIB1 Mediates Insulin-like Growth Factor I-induced Phenotypic Changes in Human Breast Cancer Cells
Cancer Res., November 15, 2004; 64(22): 8299 - 8308.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
F J Fleming, E Myers, G Kelly, T B Crotty, E W McDermott, N J O'Higgins, A D K Hill, and L S Young
Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1
J. Clin. Pathol., October 1, 2004; 57(10): 1069 - 1074.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Elkin, A. Orgel, and H. K. Kleinman
An Angiogenic Switch in Breast Cancer Involves Estrogen and Soluble Vascular Endothelial Growth Factor Receptor 1
J Natl Cancer Inst, June 2, 2004; 96(11): 875 - 878.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. W. Gregory, X. Fei, L. A. Ponguta, B. He, H. M. Bill, F. S. French, and E. M. Wilson
Epidermal Growth Factor Increases Coactivation of the Androgen Receptor in Recurrent Prostate Cancer
J. Biol. Chem., February 20, 2004; 279(8): 7119 - 7130.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. L. Smith and B. W. O'Malley
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Endocr. Rev., February 1, 2004; 25(1): 45 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. J. Fleming, A. D. K. Hill, E. W. McDermott, N. J. O'Higgins, and L. S. Young
Differential Recruitment of Coregulator Proteins Steroid Receptor Coactivator-1 and Silencing Mediator for Retinoid and Thyroid Receptors to the Estrogen Receptor-Estrogen Response Element by {beta}-Estradiol and 4-Hydroxytamoxifen in Human Breast Cancer
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 375 - 383.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. B. Lanz, S. S. Chua, N. Barron, B. M. Soder, F. DeMayo, and B. W. O'Malley
Steroid Receptor RNA Activator Stimulates Proliferation as Well as Apoptosis In Vivo
Mol. Cell. Biol., October 15, 2003; 23(20): 7163 - 7176.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Y. Lin, E. M. Resnick, and M. A. Shupnik
Truncated Estrogen Receptor Product-1 Stimulates Estrogen Receptor {alpha} Transcriptional Activity by Titration of Repressor Proteins
J. Biol. Chem., October 3, 2003; 278(40): 38125 - 38131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-A. Martin, I. Farmer, S. R. D. Johnston, S. Ali, C. Marshall, and M. Dowsett
Enhanced Estrogen Receptor (ER) {alpha}, ERBB2, and MAPK Signal Transduction Pathways Operate during the Adaptation of MCF-7 Cells to Long Term Estrogen Deprivation
J. Biol. Chem., August 15, 2003; 278(33): 30458 - 30468.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
J. Matthews and J.-A. Gustafsson
Estrogen Signaling: A Subtle Balance Between ER{alpha} and ER{beta}
Mol. Interv., August 1, 2003; 3(5): 281 - 292.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. K. Osborne, V. Bardou, T. A. Hopp, G. C. Chamness, S. G. Hilsenbeck, S. A. W. Fuqua, J. Wong, D. C. Allred, G. M. Clark, and R. Schiff
Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer
J Natl Cancer Inst, March 5, 2003; 95(5): 353 - 361.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Schiff, S. Massarweh, J. Shou, and C. K. Osborne
Breast Cancer Endocrine Resistance: How Growth Factor Signaling and Estrogen Receptor Coregulators Modulate Response
Clin. Cancer Res., January 1, 2003; 9(1): 447s - 454s.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
P. Li, X. Yu, K. Ge, J. Melamed, R. G. Roeder, and Z. Wang
Heterogeneous Expression and Functions of Androgen Receptor Co-Factors in Primary Prostate Cancer
Am. J. Pathol., October 1, 2002; 161(4): 1467 - 1474.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. W. Gregory, E. M. Wilson, K. B. C. Apparao, R. A. Lininger, W. R. Meyer, A. Kowalik, M. A. Fritz, and B. A. Lessey
Steroid Receptor Coactivator Expression throughout the Menstrual Cycle in Normal and Abnormal Endometrium
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2960 - 2966.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
I. T. R. Cavarretta, R. Mukopadhyay, D. M. Lonard, L. M. Cowsert, C. F. Bennett, B. W. O'Malley, and C. L. Smith
Reduction of Coactivator Expression by Antisense Oligodeoxynucleotides Inhibits ER{alpha} Transcriptional Activity and MCF-7 Proliferation
Mol. Endocrinol., February 1, 2002; 16(2): 253 - 270.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-J. List, K. J. Lauritsen, R. Reiter, C. Powers, A. Wellstein, and A. T. Riegel
Ribozyme Targeting Demonstrates That the Nuclear Receptor Coactivator AIB1 Is a Rate-limiting Factor for Estrogen-dependent Growth of Human MCF-7 Breast Cancer Cells
J. Biol. Chem., June 22, 2001; 276(26): 23763 - 23768.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.